71 Venous Thrombosis
• Distinction between symptoms of chronic venous disease and acute deep vein thrombosis (DVT) can be difficult. Careful attention to the time course of symptoms as reported by the patient and scrutiny of the medical record may reveal that the symptoms are less likely to be acute.
• The D-dimer blood test can be useful in the evaluation of potential DVT. Just as with pulmonary embolism, its use and interpretation need to take into account the pretest probability of disease.
• Many patients may not have classic, obvious risk factors for DVT but may still have the disease.
• The lack of 24-hour availability of duplex ultrasound, the imaging method of choice for DVT, requires a clear estimate of the probability of disease, the likelihood and timing of follow-up, and consideration of the risks and benefits of temporary empiric anticoagulation.
• Follow-up of patients is critical for monitoring the anticoagulation effects of warfarin, evaluation of progression of symptoms, and determination of the duration of anticoagulation.
Epidemiology
Deep vein thrombosis (DVT) is a common diagnosis that may be seen in emergency department (ED) patients with minimal to no symptoms or with obvious findings on examination. DVT most typically arises in the lower part of the leg and may exist in combination with or as a precursor to pulmonary embolism (PE). Together, DVT and PE are termed venous thromboembolism (VTE). Understanding VTE as a single disease is useful because risk factors, urgency in establishing a diagnosis, and treatment are similar for both PE and DVT. The annual incidence of DVT has been estimated to be 92 cases per 100,000 persons, and the rate steadily advances with increased age (32/100,000 in persons younger than 55 years, 282/100,000 in those 65 to 74 years of age, and 553/100,000 in those 75 years or older).1
Pathophysiology
Typical DVT risk factors are summarized by the Virchow triad: trauma, stasis, and hypercoagulability. These risk factors are the same as for PE (Table 71.1). However, 25% to 50% of patients with DVT may have no identifiable risk factor known at the time of evaluation.
RISK FACTORS | SPECIFIC NOTES |
---|---|
Previous history of PE or DVT | Inquire about the setting and circumstances of the previous VTE |
Recent trauma or surgery | In general, trauma requiring admission or surgery requiring general anesthesia within the previous month. Recent long-bone, vascular, or trauma surgery may especially increase the risk |
Cancer | In general, patients with currently treated cancer or palliative care |
Central or long-term vascular catheters | |
Age | Risk significantly increases above the age of 50 to 60 years |
Oral contraceptives | Especially third-generation formulations |
Hormone replacement therapy | Currently less common than in the past |
Pregnancy | Risk increases along with the duration of pregnancy; it peaks at term and then decreases over a period of 4 to 6 weeks postpartum |
Immobility | Includes casts or splints, as well as permanent limb or generalized body immobility, including that from general hospitalization |
Factor V Leiden mutation | Most common in northern European populations. The heterozygous carrier state exists in 3% to 7% of many samples. A homozygous mutation is less common and confers three times greater risk for VTE relative to the normal genotype. |
Antiphospholipid antibody syndrome | Very potent risk factor. Associated with large and recurrent PE. May be associated with anticardiolipin antibodies, stroke, myocardial infarction, and frequent first-trimester miscarriages |
Prothrombin mutation | |
Hyperhomocysteinemia | Can occur as a result of inadequate folate and B vitamin intake, as well as a genetic mutation in methyltetrahydrofolate reductase. The degree of elevation in risk is controversial |
Deficient levels of clotting factors | Protein C, protein S, antithrombin III |
Congestive heart failure | May result from generalized immobility or vascular stasis |
Chronic obstructive pulmonary disease | May result from generalized immobility |
Air travel | Primary risk with travel in excess of 5000 km (3100 miles) and concurrent other risk factors. The degree of elevation in risk is controversial |
Obesity | The degree of elevation in risk is controversial |
Differential Diagnosis and Medical Decision Making
Many other diseases may be accompanied by pain, swelling, and tenderness of the leg. Box 71.1 presents a differential diagnosis of conditions that should be considered.
Box 71.1 Differential Diagnosis of Leg Swelling